ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Stock
Total 13F shares
7,066,427
Share change
-642,199
Total reported value
$31,799,000
Price per share
$4.50
Number of holders
13
Value change
-$3,824,500
Number of buys
3
Number of sells
4

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q4 2019

As of 31 Dec 2019, ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,066,427 shares. The largest 10 holders included Canaan Partners X LLC, Sofinnova Investments, Inc., FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., GRANAHAN INVESTMENT MANAGEMENT INC/MA, Ensign Peak Advisors, Inc, UBS OCONNOR LLC, Virtu Financial LLC, NEW YORK STATE COMMON RETIREMENT FUND, and ROYAL BANK OF CANADA. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.